1. Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study. Issue 6 (22nd November 2020) Authors: Chua, Joel V.; Ntem‐Mensah, Afua; Abutaleb, Ameer; Husson, Jennifer; Mutumbi, Lydiah; Lam, Ka Wing; Ghosh, Alip; Romani, Sara; Poonia, Bhawna; Lee, Sam; Luz Pascual, M.; Frumkin, Lyn R.; Kottilil, Shyamsundaran Journal: Journal of medical virology Issue: Volume 93:Issue 6(2021) Page Start: 3752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗